Prelude Therapeutics Correlations

PRLD Stock  USD 0.85  0.01  1.74%   
The current 90-days correlation between Prelude Therapeutics and Shattuck Labs is 0.21 (i.e., Modest diversification). The correlation of Prelude Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Prelude Therapeutics Correlation With Market

Modest diversification

The correlation between Prelude Therapeutics and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Prelude Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prelude Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Prelude Stock refer to our How to Trade Prelude Stock guide.

Moving together with Prelude Stock

  0.73FATE Fate TherapeuticsPairCorr

Moving against Prelude Stock

  0.4NKTR Nektar TherapeuticsPairCorr
  0.34BAC-PL Bank of AmericaPairCorr
  0.37WFC-PL Wells FargoPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
KYMRSTOK
FHTXCCCC
PMVPFHTX
STOKFHTX
PMVPCCCC
STOKPMVP
  
High negative correlations   
PMVPSTTK
STTKFHTX
STTKCCCC
STOKSTTK

Risk-Adjusted Indicators

There is a big difference between Prelude Stock performing well and Prelude Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Prelude Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Prelude Therapeutics Corporate Management

WanJen MDSenior DevelopmentProfile
Laurent MBAChief OfficerProfile
William MDSenior DevelopmentProfile
Naveen BabbarSenior MedicineProfile
Neelesh MDVP DevelProfile
Aimee CrombieSenior OperationsProfile